A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.

Abstract

OBJECTIVE To compare efficacy of remaining on duloxetine 60 mg to increasing to 120 mg q.d. in patients without remission of major depressive disorder (MDD) after 6 weeks at 60 mg. METHOD This double-blind, parallel study was conducted in adults with MDD (DSM-IV-TR criteria). Patients initially randomly assigned to duloxetine 60 mg for 6 weeks with a 17… (More)

Topics

Cite this paper

@article{Kornstein2008ARD, title={A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.}, author={Susan G. Kornstein and David L. Dunner and Adam L. Meyers and Virgil G Whitmyer and Craig H. Mallinckrodt and Madelaine M. Wohlreich and Michael J. Detke and Millie S Hollandbeck and John H. Greist}, journal={The Journal of clinical psychiatry}, year={2008}, volume={69 9}, pages={1383-92} }